BioCentury
ARTICLE | Clinical News

North American Vaccine regulatory update

April 15, 2013 7:00 AM UTC

NVX received Swedish approval for its monovalent acellular pertussis (aP) vaccine to vaccinate children against pertussis (whooping cough). The company said the approval expands the indication in Swed...